Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Short-term Investments (2010 - 2026)

Emergent BioSolutions (EBS) posted Short-term Investments of $1.2 million for Q2 2026, little changed on a QoQ basis from $1.2 million in Q1 2026, and down 67.57% year-over-year from $3.7 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Short-term Investments (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Short-term Investments for 11 years, with the latest figure at $1.2 million in Q2 2026.

  • On a quarterly basis, Short-term Investments fell 67.57% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 67.57% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 39.34% from the prior year.
  • Short-term Investments was $1.2 million for Q2 2026 at Emergent BioSolutions, roughly flat from $1.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $6.5 million in Q3 2024, with the low at $100000.0 in Q3 2022.
  • Average Short-term Investments over 4 years is $2.5 million, with a median of $1.3 million recorded in 2024.
  • The sharpest annual moves came in 2025 and 2026: Short-term Investments jumped 640.0% in 2025, then sank 67.57% in 2026.
  • Over 4 years, Short-term Investments stood at $100000.0 in 2022, then jumped by 6000.0% to $6.1 million in 2024, then slumped by 39.34% to $3.7 million in 2025, then tumbled by 67.57% to $1.2 million in 2026.
  • The last three Short-term Investments figures came in at $1.2 million (Q2 2026), $1.2 million (Q1 2026), and $3.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 3.70 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 3.70 Mn
Mar 31, 2025 3.70 Mn
Dec 31, 2024 6.10 Mn
Sep 30, 2024 6.50 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 500,000.00
Sep 30, 2022 100,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 200,000.00
Dec 31, 2020 200,000.00
Sep 30, 2020 200,000.00
Jun 30, 2020 200,000.00
API Access

Emergent BioSolutions Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=EBS&period=max&api_key=YOUR_API_KEY